Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference4%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has updated its version from v2.16.1 to v2.16.2 and has changed the date from 2025-05-22 to 2025-06-04.SummaryDifference0.9%
- Check39 days agoChange DetectedThe web page has announced a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation.SummaryDifference6%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check82 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with the same phrase, suggesting a possible formatting or presentation change rather than a substantive content update.SummaryDifference1.0%
Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.